Materials and methods
This study is a prospective clinical pilot trial with randomization, approved by the Ethics Committee of the Reproductive Center of the First Hospital of Changde City. The study complied with the principles of the Declaration of Helsinki. All patients were well-informed and the formal consent was acquired. The females were recruited between July 2018 and December 2018 from the Reproductive Center of the First Hospital of Changde City, China.